Tumor necrosis factor and interleukin‐6 levels in hypertensive patients with and without left ventricular hypertrophy

References

• Ross R. Atherosclerosis, an inflammatory disease. N Engl J Med. 1999;340:115–126.
   PubMed Web of Science ®Google Scholar
• Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996;27:1201–6.
   Google Scholar
• McCarron RM, Wang L, Siren AL, Spatz M, Hallenback JM. Monocyte adhesion to cerebromicrovascular endothelial cells derived from hypertensive and normotensive rats. Am J Physiol. 1994;267\(pt 2):H2491–H2497.
   Google Scholar
• Liu Y, Liu T, McCarron RNI, et al. Evidence for activation of endothelium and monocytes in hypertensive rats. Am J Physiol. 1996;270\(pt 2):H2125–H2131.
   Google Scholar
• Kranzhofer R, Schmidt J, Pfeiffer CAH, Hagl S, Libby P, Kubler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19:1623–1629.
   PubMed Web of Science ®Google Scholar
• Cottone S, Vadala A, Vella MC, Mule G, Contorno A, Cerasola G. Comparison of tumor necrosis factor and endothelin-1 between essential and renal hypertensive patients. J Hum Hypertens. 1998;12(6):351–4.
   Google Scholar
• Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension. 2001;38:399–403.
   PubMed Web of Science ®Google Scholar
• Levy D, Garrison RJ, Savage DD, et al. Prognostic implica-tions of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561–1566.
   PubMed Web of Science ®Google Scholar
• Casale PN, Devereux RB, Milner M, et al. Value of echocardiographically determined left ventricular mass is predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 1986;105:173–178.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Carini G, Circo A, et al. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI Study. J Am Coll Cardiol. 2001;38(7):1829–1835.
   PubMed Web of Science ®Google Scholar
• Kapadia S, Oral H, Lee J, et al. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res. 1997;81:187–195.
   PubMed Web of Science ®Google Scholar
• Kapadia SR, Yakoob K, Nader S, Thomas JD, Mann DL, Griffin BP. Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. J Am Coll Cardiol. 2000;36(1):208–212.
   PubMed Web of Science ®Google Scholar
• Bergman MR, Kao RH, McCune SA, Holycross BJ. Myocardial tumor necrosis factor-alpha secretion in hyper-tensive and heart failure prone rats. Am J Physiol. 1999; 277:H543–H550.
   Google Scholar
• Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986; 57:450–458.
   PubMed Web of Science ®Google Scholar
• De Simone G, Daniels SR, Devereux RB, Meyer RA. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and the impact of overweight. J Am Coll Cardiol. 1992;20:1251–1260.
   PubMed Web of Science ®Google Scholar
• Lauer MS, Anderson KM, Larson MG, Levy D. A new method for indexing left ventricular mass for differences in body size. Am J Cardiol. 1994;74:487–491.
   PubMed Web of Science ®Google Scholar
• Schieffer B, Schieffer E, Hilfiker-Kleiner D, et al. Expression of angiotensin II and interleukin-6 in human coronary athero-sclerotic plaques: potential implications for inflammation and plaque instability. Circulation. 2000;101: 1372–1378.
   Google Scholar
• Gimbrone MA Jr, Nagel T, Topper JN. Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J Chin Invest. 1997;99:1809–1813.
   Google Scholar
• Chobanian AV, Alexander RW. Exacerbation of athero-sclerosis by hypertension: potential mechanisms and clinical implications. Arch Intern Med. 1996;156:1952–1956.
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Stetson S, Lakkis N, et al. Decreased expression of tumor-necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy. Circulation. 2001;103:1844–1850.
   PubMedGoogle Scholar
• Bryant D, Becker L, Richardson J, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation. 1998;97:1375–1381.
   PubMed Web of Science ®Google Scholar
• Bozkurt B, Kribbs S, Clubb M Jr. et al. Pathophysiologically relevant concentrations of tumor-necrosis factor-alpha pro-mote progressive left ventricular dysfunction and remodeling in rats. Circulation. 1998;97:1382–1392.
   Google Scholar